NCT04228484View on ClinicalTrials.gov

The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 7, 2020

Primary Completion Date

June 4, 2021

Study Completion Date

October 1, 2022

Conditions
Type2 Diabetes
Interventions
OTHER

Placebo

Placebo infusion

OTHER

GIP receptor antagonization

GIP(3-30)NH2 infusion

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT04228484 - The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter